Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility

被引：0
|
作者：
Samaras, K.
Wand, H.
Law, M.
Emery, S.
Cooper, D. A.
Carr, A.
机构：
[1] Garvan Inst Med Res, Sydney, NSW, Australia
[2] Univ New S Wales, Natl Ctr HIV Epidemiol, Clin Res, Kensington, NSW 2033, Australia
[3] St Vincent Hosp, Sydney, NSW, Australia
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：L4 / L4
页数：1
相关论文
共 50 条
  • [21] INDEPENDENT PREDICTORS OF METABOLIC SYNDROME IN HIV-INFECTED PATIENTS
    Alencastro, P. R. D.
    Fuchs, S. C.
    Ikeda, M. L. R.
    Wolff, F. H.
    Brandao, A. B. M.
    Barcellos, N. T.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A321 - A321
  • [22] Independent Predictors of Metabolic Syndrome in HIV-Infected Patients
    Alencastro, Paulo R.
    Fuchs, Sandra C.
    Wolff, Fernando H.
    Ikeda, Maria Leticia
    Brandao, Ajacio B. M.
    Barcellos, Nemora T.
    AIDS PATIENT CARE AND STDS, 2011, 25 (11) : 627 - 634
  • [23] High prevalence of metabolic syndrome among HIV-infected patients: Link with the cardiovascular risk
    Bruno, R
    Gazzaruso, C
    Sacchi, P
    Zocchetti, C
    Giodanetti, S
    Garzaniti, V
    Maffezzini, E
    Maserati, R
    Maserati, R
    Filice, G
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) : 363 - 365
  • [24] An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population
    D. F. Waterhouse
    A. M. McLaughlin
    F. Sheehan
    D. O’Shea
    Irish Journal of Medical Science, 2009, 178 : 161 - 166
  • [25] An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population
    Waterhouse, D. F.
    McLaughlin, A. M.
    Sheehan, F.
    O'Shea, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2009, 178 (02) : 161 - 166
  • [26] Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions
    Zabetian, Azadeh
    Hadaegh, Farzad
    Azizi, Fereidoun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (02) : 251 - 257
  • [27] Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children
    Jaquet, D
    Lévine, M
    Ortega-Rodriguez, E
    Faye, A
    Polak, M
    Vilmer, E
    Lévy-Marchal, C
    AIDS, 2000, 14 (14) : 2123 - 2128
  • [28] Prevalence of metabolic syndrome in a Venezuelan population by ATPIII vs IDF criteria which were compared and associated to other cardiovascular risk factors
    Brajkovich, Imperia E.
    Risquez, M. Alejandro
    Khawan, Rania
    Cevallos, Jose Luis
    Millan, Angel
    Arismendi, Zulay
    Benedetti, Paola
    Escudero, Pedro
    Escuriza, Marian
    Espana, Maria
    Gonzalez, Rosalyn
    Terrones, Orlando
    Olmos, Jose
    Urdaneta, Luis
    Vergara, Karol
    Pena, Naomi
    Suarez, Maria
    Garcia, Saladina
    DIABETES, 2007, 56 : A636 - A636
  • [29] Prevalence of metabolic syndrome estimated by IDF criteria in a Hungarian population
    Csaszar, A.
    Balogh, S.
    Kekes, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 156 - 156
  • [30] Discordance in diagnosis of osteoporosis in HIV-infected patients: prevalence, characteristics, and impact on FRAX equation
    Vizcarra, P.
    Gallego, J.
    Vivancos, M. J.
    Sobrino, C.
    Sifuentes, W. A.
    Casado, J. L.
    HIV MEDICINE, 2019, 20 : 129 - 129
12345